<DOC>
	<DOC>NCT01369836</DOC>
	<brief_summary>The purpose of this study is the following: - To evaluate the safety, tolerability, and pharmacokinetics (PK) of orally administered tafamidis in Japanese and Western healthy volunteers at single dose. - To compare Japanese and Western PK profiles. - Determine the PD stabilization effect of tafamidis on human transthyretin (TTR) in a validated ex vivo assay.</brief_summary>
	<brief_title>Study Of Single Doses Of PF-06291826 (Tafamidis) In Japanese And Western Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male or females. Body Mass Index (BMI) of 17.5 to 30.5 kg/m2. Pregnant or nursing females. Females of childbearing potential who are unwilling or unable to use an acceptable method of contraception.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Tafamidis</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>TTR stabilization</keyword>
</DOC>